Invention Grant
- Patent Title: Treatment of cancer with anti-GITR agonist antibodies
-
Application No.: US16612956Application Date: 2018-05-15
-
Publication No.: US11685787B2Publication Date: 2023-06-27
- Inventor: Suba Krishnan , Penny E. Phillips , Zheng Yang , Haiqing Wang
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- International Application: PCT/US2018/032750 2018.05.15
- International Announcement: WO2018/213297A 2018.11.22
- Date entered country: 2019-11-12
- Main IPC: A61P35/00
- IPC: A61P35/00 ; C07K16/28 ; A61K39/00
Abstract:
Provided herein are methods for treating cancer, comprising administering to a subject having cancer a therapeutically effective amount of an anti-GITR antibody alone or together with an anti-PD-1 or anti-PD-L1 antibody.
Public/Granted literature
- US20200291122A1 TREATMENT OF CANCER WITH ANTI-GITR AGONIST ANTIBODIES Public/Granted day:2020-09-17
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
